In MOGS, BRAF and NRAS mutations occur at an incidence of 2.6% and 5.3%, respectively, compared to 59–65% and 20% in cutaneous melanoma [7, 10, 19]. This evidence concerns the gene BRAF and cutaneous melanoma.